A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

Stable Coronary Heart Disease Clinical Trial

Official title:
A Phase 2a Randomized, Double-blind, Placebo-controlled, Parallel-designed Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Subjects With Stable Coronary Heart Disease

Status Completed

Clinical Trial Summary

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease.

Clinical Trial Description

A Randomized, Double-blind, Placebo-controlled, Parallel-designed Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Participants with Stable Coronary Heart Disease. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03351738
Study type	Interventional
Source	MedImmune LLC
Contact
Status	Completed
Phase	Phase 2
Start date	December 13, 2017
Completion date	November 9, 2018

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04421287` - Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD	Phase 4
Completed	`NCT02520466` - Cocoa Flavanol and Coronary Vasomotion Vascular Function in Patients With Coronary Artery Disease	N/A
Recruiting	`NCT04218487` - Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)	Phase 4
Not yet recruiting	`NCT04308551` - Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease	N/A
Completed	`NCT02947542` - Use of Different Diagnostic Coronary Catheters Over the Radial Access - the UDDC - Radial Trial	N/A